US equities
|
NVDA
$240.19
▲+0.54%
SPCX
$173.12
▲+1.19%
MU
$1,065.93
▲+0.19%
MRVL
$289.01
▲+6.55%
AMD
$654.27
▲+3.57%
INTC
$114.25
▼-1.67%
AVGO
$380.78
▲+5.04%
TSLA
$380.33
▲+0.42%
NVDA
$240.19
▲+0.54%
SPCX
$173.12
▲+1.19%
MU
$1,065.93
▲+0.19%
MRVL
$289.01
▲+6.55%
AMD
$654.27
▲+3.57%
INTC
$114.25
▼-1.67%
AVGO
$380.78
▲+5.04%
TSLA
$380.33
▲+0.42%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Ambrx Biopharma Inc.
Ambrx Biopharma Inc. Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price
December 16, 2022
From
Ambrx Biopharma Inc.
Via
Business Wire
Tickers
AMAM
Ambrx Biopharma Inc. Announces Filing of Annual Report on Form 20-F
May 02, 2022
From
Ambrx Biopharma Inc.
Via
Business Wire
Tickers
AMAM
Ambrx Biopharma Inc. Presents Positive Data from Ongoing ACE-Breast-01 Phase 1 Clinical Study of ARX788 at San Antonio Breast Cancer Symposium
December 09, 2021
From
Ambrx Biopharma Inc.
Via
Business Wire
Tickers
AMAM
